The purpose of this study was to develop a strictly controlled chemical system in vitro to evaluate the efficacy of lead (Pb) chelators. Moreover, these experiments were carried out to understand further the complex interactions between Pb chelating agents, calcium-regulating hormones, and bone cell metabolism.
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'03pb efflux (EM/CM, 0.62 * 0.06). Calcium diwdium ethylene-parathyroid hormone (PTH), calcitonin (CT), 1,25-dihydroxyvidambetetra-acetic acid at a medium ~0IICentrati00 of 0.001 mM tamin D~ [1,25-(OH)2D3], and varying concentrations of Ca and produced an equivalent net percentage of release of ' 03Pb as that p in the tissue culture medium (20, 23, 24) . The present study was measured for mM PCA. Duration of calcium disodium undertaken to clarify the effects of these physiologically important enediaminetetra-acetic acid activiv ~~S f P j l l d for 72 hr e m -effectors on PCA mobilization of lead from bone explants in vitro. pared to 48 hr for PCA. It appears, therefore, that net release of In addition, we compared the efficacy of PCA and CaNa2EDTA '03pb produced by PCA was mhmced PTK 1JYOH)aD3, in the strictly defined chemical conditions of bone organ culture, and decreased medium levels of Ca. On the other haad, the effects a method that provides a model system for the evaluation of Pbof PCA were inhibited by calcitonin and increased medium con-chelating agents. centrations of Ca or phosphate. Calcium disodium ethylene diaminetetra-acetic acid, affected by the same hormones and ionic MA~ERIALS AND METHODS changes as those in PCA cultures, appears to be considerably more potent and longer acting as a chelator of Pb than PCA in With minor modifications compared to previous reports (23, this in vitro system. 24), pregnant rats on the 18th day of gestation were given an injection of 1.0 mCi of "Pb (31) in 0.10 M acetic acid (10 to 50 Speculation mCi/mg Pb), 25 mg of lead nitrate, and 250 pCi of 46Ca (4 to 30 Ci/g Ca) as the chloride salt (31). Injection IV of both isotopes In bone organ culture, a rapidly mobile subcompartment of total and lead nitrate (25 mg), in a total volume of 1.0 ml, was bone lead (Pb) has been demonstrated to be the source of Pb accomplished by tail vein using a polyethylene tuberculin syringe chelated by ~penicillrmine (and CaNaaEDTA or calcium dim-fitted with a no. 21-gauge needle. Prior to injection, syringes and 330 DPENICILLAMINE AND ITS ACTIONS ON LEAD TRANSPORT 33 1 needles were washed with double-distilled 6 N nitric acid, obtained from G. Frederick Smith (32) , rinsed with deionized water four times, and subsequently dried and stored in a vacuum desiccator that contained silica gel (33) . One day later, paired fetal radii and ulnae, cut free from cartilage under a dissecting microscope, were obtained from Coming (34) . Five ml of modified ("pepped-up") BGJb medium (35) were added to each dish, and Fraction V of bovine serum albumin (36), after heating at 60°C for 30 min, was added to the medium to reach a final concentration of 1.0 mg/ml.
Modified BGJb medium was similar to that originally described by Gwatkin et al. with some modfications (35) . The glucose concentration was 1 @liter, and ascorbic acid and sodium acetate were added at 50 and 100 mg/liter, respectively, The concentrations of Ca, Mg, and P were varied in some experiments, but the standard medium contained 1.40 mM Ca, 1.0 mM P, and 0.80 mM Mg. The medium was made up freshly for each experiment from concentrated solutions of salts and amino acids (stored at 4°C) and vitamins and cofactors maintained at -20°C. Before use, concentrated sodium carbonate solution was added under a humidified atmosphere of 5% COz in air at 37°C to bring the pH of the medium between 7.30 and 7.40. These were the basic conditions for culture experiments.
After addition of all constituents, the peppedup BGJb medium was sterilized through a 0.22-xnp membrane filter (37) . Penicillin, streptomycin, and tetracycline were added to all media at concentrations of 100,000 units/liter, 50 mg/liter, and 1 mdliter, respectively. All bones (lO/culture dish) were paired from fetuses from an individual pregnant rat and placed in this standard medium for an initial period of 24 hr, so that the subsequent release for 24 hr of previously incorporated M3Pb and "Ca from bone explants to the medium was largely the result of physicochemical exchange. Each experiment was terminated at 48 hr after the 24-hr preculture period unless stated dflerently, and control and experimental media were changed every 24 to 48 hr.
In some experiments, stable Pb content of bones was measured by drying bones (10 bones per crucible) at 100°C to a constant weight that was determined on a Cahn no. 4700 electrobalance (38) with an accuracy to 0.10 pg. Bones were then ashed in acidwashed coors crucibles at 400°C for 6 to 8 hr, and the bone ash was dissolved in 0.5 ml of 6 N HN03 (23, 24) . Thereafter, solubilized bones were measured for Pb content on a Varian-Techtron AA-6D atomic absorption spectrometer (39) with simultaneous automatic background correction at the 2,170 wavelength. Pb analyses were carried out by flameless atomic absorption on a model 90 carbon rod atomizer, according to methods described previously (1 8, 2 1-24, 28).
The standard curve was defined by the use of aqueous standards (10 to 150 &dl); and 1 ml of double distilled concentrated nitric acid in vycor, obtained from G. Frederick Smith (32), was added to each 100 ml of the working standards. All standards were stored in acid-washed polyethylene bottles and made up fresh each wk. The accuracy of the standards and absolute recove of stable lead were determined by addition of tracer amounts ofxPb, obtained from New England Nuclear (31) plus carrier Pb from VarianTechtron Pb standards (39) to provide the concentrations noted above. Recovery of stable Pb averaged 97 to 101%; and mPb was measured as noted below. The following chemicals and hormones were used: PTH (1-34) synthetic tetratriacontapeptide (3885 units/ mg) was obtained from Beckman Bioproducts (40); 1,25-(OH)2D3 in 1Wo alcohol was a gift from Dr. H. F. DeLuca; synthetic salmon calcitonin, 2000 MRC units/mg, was a gift from Dr. J. Lesh of the Armour Company (41). All of these hormones were stored at -40°C until use. CaNazEDTA (200 mg/ml) was supplied without any additives as a sterile solution from Riker Laboratories (42); pure, crystalline PCA was a pft from The Merck, Sharp and Dohme Co. (43); all acids (double distilled in vycor) and all reagents were obtained from G. Frederick Smith (32) or were Baker (33) and SchwarzMann (44) Ultrex-or Ultra-pure grades, respectively. All hormones and chelators were dissolved directly into the medium. When 1,25-(OH)~D3 was used, the concentration of alcohol did not exceed a final medium concentration of 1%, and the same amount of alcohol was added to control media.
Measurement of the gamma emission (0.279 MeV) of m3Pb in bones and media (1 ml) was carried out on a Searle Analytic (45) model 1185 gamma counter. All measurements of 203Pb were corrected for radiodecay by comparison to 5 standards (0.10 to 0.50 pCi) of mPb prepared at the time of injection of the animals. These standards were counted at the time of tail vein injection, every 24 hr thereafter, and when mPb was measured in the experimental and control media at the end of a 48-hr experiment. All measurements of m3Pb were subtracted from background radioactivity. "~a in 0.10 p1 of medium was measured by liquid scintillation counting utilizing an Isocap I1 counter (49, and Biofluor, obtained from New England Nuclear (3 l), was the liquid scintillation fluid.
The effect on the release of ' 03Pb and "Ca by changing one variable (addition of a hormone, chelator, or one ionic medium change) was referred to as the experimental medium (EM), and the final calculations were expressed as the cpm released after 48 hr into the EM divided by the cpm in the appropriate control medium (CM), EM/CM ratios. All data were stored in a Modular Systems Computer (46); and EM/CM ratios different from 1.00 according to Student's t test were calculated by a computer program. EM/CM ratios different from 1.00 at a P value of < 0.05 or < 0.01 were considered significantly different from appropriate control cultures. In some experiments, the percentage of release of totally preincorporated label at 48 hr was calculated by a different computer program by dividing the net cpm of label released into the medium by the net cpm measured in bone explants after 48 hr of culture.
RESULTS
Throughout this study, we found consistent dose-related effects of various agents on the net release of m3Pb from fetal rat bones. Neghgible EM/CM ratios (so. 10) were quantitated in heat-killed compared to live bones. Thus, active cell-mediated inhibition or stimulation of bone resorption was present as indicated in Tables  1 to 6 . When -pb and stable Pb were measured concurrently (Tables 1 and 6 ), a proportional net loss or gain of stable and radioactive lead was evident in response to various changes in the medium (addition of chelators, hormones, or ionic changes). These results confirm further that active cell-mediated inhibition or stimulation of Pb transport was present rather than physicochemical exchange, particularly in view of the 24-hr preculture period in control medium.
Increasing concentrations of PCA from 1.0 to 10.0 mM in the culture medium led to increasing 203Pb efflux from fetal rat bones as evidenced by ~i g n~c a n t l y increased EM/CM ratios ( Table I) .
Above 10 mM PCA, no further release of mPb into the medium was observed. When PTH was added to the medium, however, an increased EM/CM ratio was evident at a lower concentration of PCA (0.10 mM) ( Table 2 ; Fig. 1 ). This concentration of PCA in the absence of PTH had failed to produce a significant EM/CM ' Means * S.E. of 6 to 10 culture dishes (10 bones per dish).
Significant change in bone Pb content, P < 0.01.
' Simcantly different from 1.00, P < 0.01.
Signif~cantly different from 1.00, P < 0.001. 'Significant change in bone Pb content, P < 0.001. Media contained Ca and P at the standard concentrations and 100 ng/ ml of PTH was added to all media.
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Mean * I S.E. of 6 to 10 culture dishes (10 bones per dish).
Significantly different from 1.00, P < 0.01.
' Si@lcantly different from 1.00, P < 0.001. Different from 1.00, P < 0.00 1.
' Different from 1.00, P < 0.01. 'Different from PCA + 1,25-(OH)2D3 in the standard medium, P < 0.01.
' Different from PCA + 1,25-(OH)~Ds in the standard medium, P < 0.001. ratio for mPb. With PCA and PTH in the medium, a plateau effect was achieved again, but at a lower PCA concentration (5.0 mM) than with PCA alone (Fig. 1) . The combination of PCA and PTH in the medium produced a signficant rise in "Ca release from embryonic bones to the medium, whereas none was present with PCA cultures alone (Tables 1 and 2 ). Thus, it appeared that PCA and PTH together enhanced the release of mPb. Experiments with 1,25-(OH)zD3 and PCA in the media, as with PTH, showed greater EM/CM ratios than with PCA alone (Table  3) . Moreover, in the same group of experiments, decreasing the medium concentration of Ca to 0.70 mM in PCA cultures produced a significantly greater net release of mPb as shown by the higher EM/CM ratio in Table 3 . No si@icant changes in EM/ CM ratios were observed in any of these experiments when the Mg concentration in the medium was lowered to 0.40 mM or raised to 1.60 mM. In contrast, increasing media concentrations of Ca, P, or the addition of CT to the media inhibited the release of mPb (Tables 3 and 4) . Moreover, CT, particularly in combination with increasing medium levels of P, appeared to have an additive effect in inhibiting the net release of mPb (Table 4) .
Data for the effects of CaNazEDTA and PTH with various ionic concentrations in the media are presented in Table 5 . At a CaNa2EDTA concentration of 0.001 mM in the absence of PTH, a significant EM/CM ratio was evident. Inhibition of mPb release was apparent in these cultures because the phosphate concentration was increased from 1.00 to 4.00 mM, similar to the effects of phosphate in PCA cultures. In addition, decreasing or increasing medium levels of Ca resulted in higher and lower EM/CM ratios, respectively, as in PCA cultures.
Inasmuch as changes in the medium concentrations of Ca and P produced highly significant changes in the release of mPb in PCA cultures alone or in cultures that included PCA, chelators, and/or hormones, the effects of modifying medium levels of Ca and P were investigated in the absence of any chelators or hormones. It was found that increasing the concentrations of Ca and P in the medium produced mild but significant decreases in EM/ CM ratios (Table 6 ). Opposite effects were apparent when the concentrations of these ions were lowered. Although mild effects were noted, as delineated in Table 6 , ionic changes in the medium in the presence of PCA, CaNa2EDTA, 1,25-(OH)zDe and CT produced far more pronounced elevations or decrements in EM/ CM jatios (see Tables 3 to 5 ). Because proportional losses or ' Mean f S.E.
Significantly different from 1.00, P < 0.0 1.
' Significantly different from EM/CM ratios in standard medium, P < 0.01.
SigIllficantly different from 1.00, P < 0.00 1.
' SigIllf~cantly different from EM/CM ratios in standard medium, P < 0.001. Significantly different from 1.00, P < 0.01.
' Significantly different from 1.00, P < 0.001.
%M/CM ratio different from that found in the standard medium, P < 0.001.
' EM/CM ratio different from that found in the standard medium, P < 0.01.
relative gains in the stable Pb content of bones were demonstrated (Table 6) , it is reasonable to suggest that these ionic chan es alone modified to an extent active cell-mediated transport of ' Pb. A comparison of the relative potency of CaNaZEDTA and PCA revealed equivalent net release of mPb at a CaNazEDTA concentration of 0.001 mM (13.1 * 0.9%) compared to a PCA concentration of 1.0 mM (12.9 f 0.82%). This represents a thousandfold difference between CaNazEDTA and PCA's ability to effect mPb release from bone explants to the medium. Further evaluation of this finding was defined by timed studies (Fig. 2) . PCA activity peaks in the first 48 hr and then dissipates over the next 24 hr to statistically insignificant EM/CM ratios. In contrast, CaNazEDTA actions on ' 03Pb efilux were sustained throughout the 72-hr culture period. Transfer of the PCA-treated bones to fresh medium at 72 Underlined ion concentrations are those in the standard medium.
* Mean f S.E. for 6 to 12 culture dishes (10 bone per dish).
Significantly different Pb content of bones cultured in standard medium, P < 0.05.
' Significantly different from 1.00, P < 0.05.
Significantly different Pb content of bones cultured in standard medium, P < 0.01.
' Significantly different from 1.00, P < 0.01.
hr resulted in a similar pattern; significantly increased EM/CM ratios were found for PCA-treated bones for 48 hr only compared to a continuous culture period of 72 hr for CaNazEDTA. Thus, CaNazEDTA-treated bones effected significant EM/CM ratios for a considerably longer culture period, and a change to fresh medium at 48 hr was not necessary to effect significant EM/CM ratios in CaNazEDTA experiments.
DISCUSSION
Our data confirm previous findings in rats (1 l), namely, that PCA caused a signikicant reduction of previously incorporated radiolead from the skeleton. The in vitro data reported herein also support the major effect of CaNazEDTA on the mobilization of Pb from bone demonstrated in vivo by Hammond and Aronson (10, 12) .
The same regulatory hormones and ions that control bonemineral homeostasis affect Pb in a relatively similar fashion. PCA, as a Pb chelator, becomes superimposed upon many complex factors that control mineral metabolism and Pb's interactions with bone. Several augmenting effects of PCA and CaNazEDTA on Pb chelation have been shown in this study. However, extrapolations to in vivo situations by varying the concentration of calcium or phosphorus in the medium (extracellular fluid) or the addition of calcium-regulating hormones must be viewed with caution in extending our in vitro data to man.
Several lines of evidence support active cell-mediated mobilization of lead from bone by PCA: (1) in our study, heat-killed bones failed to produce significant release of mPb compared to reproducible dose-response relationships reflected in EM/CM ratios for live bones treated with PCA; (2) morphologic confirmation of PCA's and CaNazEDTA effects on Pb transport has been defined by electron microscopy (19) . Typical lead inclusion bodies were induced in bone organ culture by 72 hr. These inclusions were found in the nucleus and cytoplasm of osteoclasts adjacent to nuclear pores, similar to those produced in renal cortical cells in vivo. The bones were washed in standard medium and cultured in medium to which 1.0 to 10.0 mM PCA or 0.01 to 0.05 CaNazEDTA had been added. Electron microscopy revealed Timed studies that indicate the more sustained effects of CaNa2EDTA (0.001 mM) compared to PCA (1.00 mM). PCA' s effects on mPb release are dissipated within 48 hr. CaNa2EDTA has a more sustained action on mPb release from bone explants to the medium.
that Pb inclusions had disappeared, and vacuoles containing amorphous material were common. Similar findings have been reported in renal cortical cells after treatment with CaNazEDTA in vivo (8) .
The changes in EMICM ratios produced by modifications in medium levels of Ca and P were striking, and although the changes are largely unexplained to date, several explanations may be entertained. Calcium deficiency in rats has been shown to markedly increase osteoclast numbers and bone resorbing surfaces (29) . Other studies, however, have demonstrated that elevated medium calcium allows the first formation of mineral within bone matrix vesicles (1). This latter process is also dependent on the availability of phosphate. The mineralization process may be enhanced by enzymatic hydrolysis of phosphate esters or pyrophosphate to release phosphate thereby allowing reaction with Ca to form apatite (25) . A contributing mechanism that may explain the elevated Ca effects in the media is related to this ion's ability to alter the activity of the adenyl cyclase system, one of the important modulators of PTH's actions (7, 13, 14, 25, 30) . Thus, the concentrations of Ca and P in the medium may influence significantly bone resorption and mineralization by cellular and organelle-dependent interactions (1, 7, 13, 14, 25, 30) . 203Pb and stable Pb release from bones was modified by changes in medium concentrations of Ca and P to an extent that was considerably greater when PCA or CaNazEDTA were added to the medium (Table 1) .
In addition, it is possible that modification of the ionic concentration of the media may alter the permeability of plasma membranes, thereby modifying the transport of other ions that themselves bring about changes in bone cell metabolism (1, 7, 13, 14, 25, 30) . As noted in Table 6 , medium ionic changes themselves alter to an extent the release of 203Pb from fetal rat bones to the medium. However, when chelators and hormones were added to the medium containing different concentrations of Ca and P, these changes (Tables 3 to 5 ) became far more pronounced. It is reasonable to suggest, therefore, that chelators alone or in concert with calcium-regulating hormones have an additive modifying effect on bone cell metabolism. In view of the interactions of Ca, Pb and P in several biological systems, (17, 20) , it is reasonable to postulate that Pb chelation from intracellular sites redistributes Ca in the cytosol and modifies bone cell metabolism of Ca. These events would probably affect the actions of calcium-regulating hormones (1, 7, 13, 14, 25, 30) .
PTH and 1,25-(OH)ZDS-treated bones also stimulate osteoclast activity and bone resorption (4,5) with release of collagenases into the media as observed in vitro (4, 5) . This activity is inhibited by increasing amounts of medium phosphate (4, 5) . Moreover, high P concentrations could inhibit cellular mechanisms which are required for bone cell transport of several ions (3).
It is not surprisiing that the net release of 2 0 3~b was considerably higher than that measured for ' %2a. This was anticipated because PCA and CaNa2EDTA are chelators relatively specik for Pb (6) . Moreover, as demonstrated in this study, the media concentrations of PCA and CaNazEDTA (in the calcium salt form of EDTA) were not sufficient to produce demineralization of bone shafts. We conclude, therefore, that in this in vitro system, "physiological" concentrations of chelators were added to the various media. Significant changes in &Ca EM/CM ratios occurred only when known hormonal stimulators (PTH and 1,25-dihydroxyvitamin D3) or inhibitors (CT) of bone resorption were introduced into the media.
PCA was noted to have a time-limited action on 203Pb EM/CM ratios (Fig. 2) . This may relate to competitive biding to other cations (6, 18, 21) . Of possible clinical importance would be binding to trace metals such as zinc, chromium, copper, and other trace metals at different tissue sites. At present, no clinical deficiency states of these metals have been reported with PCA therapy. However, after completion of in-hospital treatment with CaNa2EDTA, patients undergoing outpatient treatment of undue Pb absorption with PCA have been noted to have mild-to-moderate decreases in serum levels of zinc and copper (48) . In addition, a possible explanation for this observation in vitro may be related to different biochemical properties of EDTA and PCA (6). EDTA does not undergo metabolic changes in vivo, so that it is reasonable to suggest that the EDTA moiety remains intact in vitro. In contrast, PCA is active as a chelator only in its sulphydryl form (6); and PCA can be readily converted to a disulphide, which would be inert as a metal chelator. It can be argued, therefore, that reducing agents in fresh medium generate reduced PCA to its active form, thereby accounting for the restoration of activity between 72 and 120 hr (Fig. 2) . Lastly, PCA may have effects on Pb chelation at tissue sites other than bone. However, based upon the timed studies (Fig. 2) , divided daily doses of PCA for treatment of increased Pb absorption appears warranted in children once a five-day course of CaNazEDTA therapy has been completed successfully.
Depletion of Pb and other essential trace metals from bone explants in the same in vitro system have been confirmed by an alternative method of analysis. By the use of proton-induced Xray emission, a method sensitive at the subnanogram level, analysis of stable Pb and other essential trace metals (zinc, chromium, and manganese) has shown dose-related decreases after fetal rat bones were cultured with CaNa2EDTA (0.001 to 0.05 mM) or PCA (1.0 to 10.0 mM) (18, 21) .
The equipotence of CaNazEDTA (0.001 mM) and PCA (1.00 mM) occurred within the general range of concentrations of CaNazEDTA that were measured experimentally in vivo during administration of the former chelator in calves (2) . This general observation supports differences in potencies of CaNazEDTA and PCA in the few experimental studies camed out to date (2, 6, 11) . The findings in this study are not meant to imply that PCA is not a useful clinical chelator under the conditions usually applied to appropriate clinical situations. We do suggest, however, that more strictly controlled ,clinical comparisons of CaNazEDTA and PCA are indicated (26) . Based upon the demonstrations of a transient rise of brain Pb in PCA-treated rats (1 I), such a trial may not be appropriate in children whose increased susceptibility to undue absorption of Pb has been clearly shown (6, 20) .
This model provides a strictly controlled, chemically defined system to study in vitro the organ, organelle, and molecular actions of chelators. We suggest that it is likely to permit a clearer definition of the physiological and biochemical processes in bone Pb and mineral metabolism. By so doing, a framework for more eff~cacious and safer treatment of Pb toxicity in children may be established.
